Use of Wearables in Hospitalized General Medicine Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

October 5, 2019

Study Completion Date

November 1, 2019

Conditions
Hospitalizations
Interventions
DEVICE

Fitbit Charge 2

The Fitbit Charge 2 is the electronic wearable chosen for this pilot study. This particular Fitbit is capable of measuring patient heart rate, sleep and physical activity. The data collected will then be analyzed with respect to the outcomes of this study. To determine the accuracy of the Fitbit, data collected will be compared to the nurses' standard patient assessment (for HR and physical activity) and to patient responses on the Richards-Campbell Sleep Questionnaire (for sleep).

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03646435 - Use of Wearables in Hospitalized General Medicine Patients | Biotech Hunter | Biotech Hunter